Does Medicaid Pay Too Much for Prescription Drugs? A Case Study of Atypical Anti-Psychotics

Mark Duggan

No 9626, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: During the last several years, government spending on drugs used to treat schizophrenia and other psychotic illnesses has increased at more than 30% per year, with the $3 billion in 2001 Medicaid expenditures exceeding spending in any other therapeutic category. This growth has been primarily driven by a shift to atypical anti-psychotic drugs, which are several times more expensive than the conventional anti-psychotics that preceded them and are purchased almost exclusively by state governments through the Medicaid program. In this paper, I estimate the productivity of these new drugs using a 5% sample of California Medicaid recipients eligible for the program in at least one month between January of 1993 and December of 2001 and diagnosed with schizophrenia during that period. My results indicate that the shift to atypical anti-psychotics has significantly increased government spending, has not reduced the utilization of hospitals or long-term care facilities, and has not improved observable measures of health among Medicaid recipients. The findings suggest that the price of a prescription drug purchased differentially by consumers with Medicaid or other public health insurance may be an inaccurate measure of it value to patients.

JEL-codes: H51 H57 (search for similar items in EconPapers)
Date: 2003-04
New Economics Papers: this item is included in nep-hea, nep-ias, nep-lab and nep-mac
Note: EH
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Published as Duggan, Mark. "Do New Prescription Drugs Pay For Themselves?: The Case Of Second-Generation Antipsychotic," Journal of Health Economics, 2005, v24(1,Jan), 1-31.

Downloads: (external link)
http://www.nber.org/papers/w9626.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:9626

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w9626

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().